Learning multiple sclerosis immunopathogenesis from anti-CD20 therapy | PNAS
An Overview of CD20 Monoclonal Antibodies Drugs- CUSABIO
CD20 mutations involving the rituximab epitope are rare in diffuse large B-cell lymphomas and are not a significant cause of R-CHOP failure | Haematologica
CD20 Antigen Things to Know | Massive Bio
CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties | Scientific Reports
The future of anti-CD20 monoclonal antibodies: are we making progress? - ScienceDirect
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
CD20 - IHC Primary Antibodies-FR
CD 20 Chansons et comptines pour les petits vol 3
Protéine CD20 pleine longueur exprimée HEK293 avec Nanodisc / DDM / VLP - ACROBiosystems
Brain Sciences | Free Full-Text | Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab
Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab | Science
Frontiers | Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives | Journal of Neurology
Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis | CNS Drugs
Unraveling the T–B tangle in anti-CD20 multiple sclerosis therapy | PNAS
CD20 antigen structure and organization into membrane bilayers. (A) The... | Download Scientific Diagram
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
The future of anti-CD 20 monoclonal antibodies : are we making progress ? | Semantic Scholar
CD20 — Wikipédia
Frontiers | Anti-CD20 B Cell Treatment for Relapsing Multiple Sclerosis
CD-20 - Micromega
The reduction of B cells by anti-CD20 antibodies includes 6 mechanisms.... | Download Scientific Diagram
